Pregled bibliografske jedinice broj: 1073166
Cardiopulmonary Bypass in Infective Endocarditis Patients
Cardiopulmonary Bypass in Infective Endocarditis Patients // The Journal of Cardiovascular Surgery. Abstract book. / Castellani, L (ur.).
Saluzzo: Minerva Medica, 2012. str. 161-161 (predavanje, međunarodna recenzija, sažetak, stručni)
CROSBI ID: 1073166 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Cardiopulmonary Bypass in Infective Endocarditis
Patients
Autori
Mrkonjić, Ružica ; Sentić, Marko ; Marušić, Natalija ; Solarić, Mladen ; Lukačević, Nenad
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, stručni
Izvornik
The Journal of Cardiovascular Surgery. Abstract book.
/ Castellani, L - Saluzzo : Minerva Medica, 2012, 161-161
Skup
The 61st International Congress of the European Society of Cardiovascular and Endovascular Surgery
Mjesto i datum
Dubrovnik, Hrvatska, 25.04.2012. - 28.04.2012
Vrsta sudjelovanja
Predavanje
Vrsta recenzije
Međunarodna recenzija
Ključne riječi
infective endocarditis, cardiopulmonary bypass
Sažetak
Aim: Infective endocarditis is a disease of the heart, but it is also a multisystem disorder where inflammatory response further worsens as the result of the interaction between white blood cells, platelets, endothelial cells, various cytokines and the bacterium. Due to this reason, infective endocarditis remains a challenging disease to manage during cardiopulmonary bypass (CPB). The aim of this study is to summarize the management experience of CPB during valve replacement for infective endocarditis. Methods:Between January 2000 and January 2012 in our hospital valve replacement was performed in 74 cases of infective endocarditis, 61(82%) male and 13(18%) female patients. The mean age was 50.1 years. CPB was performed using moderate to normal temperature ( 29-37°C ) and moderate to high flow rates (1.9-3.0 l/min/m2). Myocardial protection was identical for all patients and consisted of an anterograde and retrograde cold blood crystalloid cardioplegia (4:1) with topical ice slush. Pathophysiologal events and its clinical presentations during CPB, complications and mortality were recorded and analysed. Results: The most common causes of infections were Staphylococcus aureus, Staphylococus epidermidis, MRSA/MRSE and Enterococcus faecalis. Mean duration of CPB: 126 minutes Ao clamp: 80 minutes Administration of infusions during CPB: n= 46 (62%) patients, average volume 1086ml Hemofiltration: 29 ( 39%) patients Average volume of hemofiltration : 1645ml Htc before CPB: 28% Transfusion requirement during CPB: n= 56(76 %) patients Mean total RBC transfusion during CPB (keep HCT > 20%): 604ml ACT before CPB after initial heparin: 469 sec Extra Heparin during CPB (keep ACT>480) : n= 68 (92%) patients Average dose of extra Heparin: 325 mg/kg CPB vasopressor requirement :n=47 (64%) patients The average dose of vasoconstrictors: 0, 0526mg/kg Conclusions The main challenges for perfusion during valve replacement in infective endocarditis patients were handeling systemic pressure due to vasoplegic syndrome and adequate anticoagulation.
Izvorni jezik
Engleski
Znanstvena područja
Biotehnologija u biomedicini (prirodno područje, biomedicina i zdravstvo, biotehničko područje)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE